Details

Autor(en) / Beteiligte

• Okamoto, Hiroyuki
• Okuma, Kae
• Nakayama, Hiroki
• Nakamura, Satoshi
• Iijima, Kotaro
• Chiba, Takahito
• Takemori, Mihiro
• Fujii, Kyohei
• Mikasa, Shohei
• Nakaichi, Tetsu
• Aikawa, Ako
• Katsuta, Shouichi
• Igaki, Hiroshi

Titel

In vivo dosimetry for testicular and scalp shielding in total skin electron therapy using a radiophotoluminescence glass dosimeter

Ist Teil von

• Journal of radiation research, 2022-01, Vol.63 (1), p.51-54

Ort / Verlag

England: Oxford University Press

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• Abstract Mycosis fungoides (MF) is a common, low-grade non-Hodgkin’s lymphoma of skin-homing T lymphocytes that can be treated via skin-directed radiotherapy. Our institution has implemented total skin electron therapy (TSET) with a 4.3 m source-to-surface distance (SSD) and 6 MeV electron beams with a beam spoiler. A 35-year-old male undergoing TSET desired to avoid radiotherapy-induced hair loss and temporary infertility; therefore, leakage dose to scalp and testicles was reduced with a special radiation shield composed of stacked lead sheets. The shields for the scalp and scrotal were of 3 mm and 6 mm, respectively. To assess leakage doses, a radiophotoluminescence glass dosimeter (RPLD) was placed at every fraction. The difference dose between the measured and prescribed dose at the calibration point was 2%. The top of the head and scrotal surface exhibited 18 cGy and 10 cGy, respectively. Thus, the dose to the scrotal surface was not beyond the testicular tolerance dose of 20 cGy. Results of semen analysis two months postradiotherapy were normal. There was no hair loss during or after radiation therapy. Therefore, the RPLD is a useful in vivo dosimeter that provides technical information on radiation shielding to allow for completion of TSET without hair loss or temporary infertility.